Department of Public Health Sciences, University of Alberta, Edmonton, Alberta, Canada.
Ann Fam Med. 2012 Nov-Dec;10(6):538-46. doi: 10.1370/afm.1405.
Influenza and pneumococcal vaccination rates remain below national targets. We systematically reviewed the effectiveness of quality improvement interventions for increasing the rates of influenza and pneumococcal vaccinations among community-dwelling adults.
We included randomized and nonrandomized studies with a concurrent control group. We estimated pooled odds ratios using random effects models, and used the Downs and Black tool to assess the quality of included studies.
Most studies involved elderly primary care patients. Interventions were associated with improvements in the rates of any vaccination (111 comparisons in 77 studies, pooled odds ratio [OR] = 1.61, 95% CI, 1.49-1.75), and influenza (93 comparisons, 65 studies, OR = 1.46, 95% CI, 1.35-1.57) and pneumococcal (58 comparisons, 35 studies, OR = 2.01, 95% CI, 1.72-2.3) vaccinations. Interventions that appeared effective were patient financial incentives (influenza only), audit and feedback (influenza only), clinician reminders, clinician financial incentives (influenza only), team change, patient outreach, delivery site changes (influenza only), clinician education (pneumococcus only), and case management (pneumococcus only). Patient outreach was more effective if personal contact was involved. Team changes were more effective where nurses administered influenza vaccinations independently. Heterogeneity in some pooled odds ratios was high, however, and funnel plots showed signs of potential publication bias. Study quality varied but was not associated with outcomes.
Quality improvement interventions, especially those that assign vaccination responsibilities to nonphysician personnel or that activate patients through personal contact, can modestly improve vaccination rates in community-dwelling adults. To meet national policy targets, more-potent interventions should be developed and evaluated.
流感和肺炎球菌疫苗接种率仍低于国家目标。我们系统地回顾了质量改进干预措施对提高社区居住成年人流感和肺炎球菌疫苗接种率的有效性。
我们纳入了随机和非随机研究,并设置了同期对照组。我们使用随机效应模型估计了汇总优势比,并使用唐斯和布莱克工具评估了纳入研究的质量。
大多数研究涉及老年初级保健患者。干预措施与提高任何疫苗接种率相关(77 项研究中的 111 项比较,汇总优势比 [OR] = 1.61,95%置信区间,1.49-1.75),以及流感(93 项比较,65 项研究,OR = 1.46,95%置信区间,1.35-1.57)和肺炎球菌(58 项比较,35 项研究,OR = 2.01,95%置信区间,1.72-2.3)疫苗接种率。似乎有效的干预措施包括患者经济激励(仅流感)、审核和反馈(仅流感)、临床医生提醒、临床医生经济激励(仅流感)、团队变更、患者外展、接种点变更(仅流感)、临床医生教育(肺炎球菌)和病例管理(肺炎球菌)。如果涉及个人接触,患者外展会更有效。然而,在护士独立接种流感疫苗的情况下,团队变更更有效。然而,一些汇总优势比的异质性很高,漏斗图显示出潜在的发表偏倚迹象。研究质量各不相同,但与结果无关。
质量改进干预措施,特别是将疫苗接种责任分配给非医生人员或通过个人接触激活患者的干预措施,可以适度提高社区居住成年人的疫苗接种率。为了达到国家政策目标,应该开发和评估更有效的干预措施。